Cargando…
WGS characterization of MDR Enterobacterales with different ceftolozane/tazobactam susceptibility profiles during the SUPERIOR surveillance study in Spain
OBJECTIVES: To analyse by WGS the ceftolozane/tazobactam (C/T) resistance mechanisms in Escherichia coli and Klebsiella spp. isolates recovered from complicated intra-abdominal and urinary tract infections in patients from Spanish ICUs (SUPERIOR surveillance study, 2016–17). METHODS: The clonal rela...
Autores principales: | Hernández-García, Marta, García-Fernández, Sergio, García-Castillo, María, Bou, Germán, Cercenado, Emilia, Delgado-Valverde, Mercedes, Mulet, Xavier, Pitart, Cristina, Rodríguez-Lozano, Jesús, Tormo, Nuria, López-Mendoza, Diego, Díaz-Regañón, Jazmín, Cantón, Rafael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210196/ https://www.ncbi.nlm.nih.gov/pubmed/34223039 http://dx.doi.org/10.1093/jacamr/dlaa084 |
Ejemplares similares
-
Antimicrobial activity of ceftolozane-tazobactam against Enterobacterales and Pseudomonas aeruginosa recovered during the Study for Monitoring Antimicrobial Resistance Trends (SMART) program in Spain (2016-2018)
por: Cantón, Rafael, et al.
Publicado: (2021) -
Imipenem-Relebactam Susceptibility in Enterobacterales Isolates Recovered from ICU Patients from Spain and Portugal (SUPERIOR and STEP Studies)
por: Hernández-García, Marta, et al.
Publicado: (2022) -
Activity of imipenem/relebactam against Enterobacterales and Pseudomonas aeruginosa in Spain. SMART 2016-2020
por: García-Fernández, Sergio, et al.
Publicado: (2023) -
Evaluation of Ceftolozane/Tazobactam, Ceftazidime/Avibactam and Meropenem/Vaborbactam Against Multidrug-Resistant (MDR) Pseudomonas
por: Shamsulddin, Haider, et al.
Publicado: (2021) -
Ceftolozane-tazobactam in nosocomial pneumonia
por: Candel, Francisco Javier, et al.
Publicado: (2022)